Contrast sensitivity and visual recovery time in diabetic patients treated with panretinal photocoagulation
Research output: Contribution to journal › Article
Standard
Contrast sensitivity and visual recovery time in diabetic patients treated with panretinal photocoagulation. / Lövestam Adrian, Monica; Svendenius, Nils; Agardh, Elisabet.
In: Acta Ophthalmologica Scandinavica, Vol. 78, No. 6, 2000, p. 672-676.Research output: Contribution to journal › Article
Harvard
APA
CBE
MLA
Vancouver
Author
RIS
TY - JOUR
T1 - Contrast sensitivity and visual recovery time in diabetic patients treated with panretinal photocoagulation
AU - Lövestam Adrian, Monica
AU - Svendenius, Nils
AU - Agardh, Elisabet
PY - 2000
Y1 - 2000
N2 - PURPOSE: To study patients treated with panretinal photocoagulation regarding contrast sensitivity and visual recovery time after exposure to glare. METHODS: To compare contrast sensitivity and visual recovery-time after exposure to glare in eyes (n=20) from 20 type 1 diabetic patients treated with panretinal photocoagulation for proliferative retinopathy with eyes (n= 19) from 19 un-treated type 1 diabetic patients. Contrast sensitivity was tested with a low contrast acuity chart, before and during exposure to either a uniform background illumination or a spotlight. Visual recovery time was defined as the time required to regain baseline visual acuity during light exposure. RESULTS: Contrast thresholds values were higher in eyes treated with panretinal photocoagulation compared to un-treated eyes before illumination 4.2 +/- 1.2% vs. 3.1 +/- 1.7% (p=0.006), during background illumination 5.8 +/- 5.1% vs. 3.9 +/- 4.8% (p=0.001), and during spotlight exposure 5.6 +/- 2.2% vs. 3.2 +/- 1.8% (p<0.001). Furthermore, recovery time was longer both during background illumination, 20; 5-50 sec vs. 2; 2-80 sec. (md;range), (p<0.001) and during spotlight illumination 27; 5-70 sec vs. 2;1-60 sec. (md;range) (p<0.001). CONCLUSION: Eyes treated with panretinal photocoagulation had higher contrast threshold levels at baseline and during glare, as well as a prolonged visual recovery time compared to un-treated eyes with mild background retinopathy.
AB - PURPOSE: To study patients treated with panretinal photocoagulation regarding contrast sensitivity and visual recovery time after exposure to glare. METHODS: To compare contrast sensitivity and visual recovery-time after exposure to glare in eyes (n=20) from 20 type 1 diabetic patients treated with panretinal photocoagulation for proliferative retinopathy with eyes (n= 19) from 19 un-treated type 1 diabetic patients. Contrast sensitivity was tested with a low contrast acuity chart, before and during exposure to either a uniform background illumination or a spotlight. Visual recovery time was defined as the time required to regain baseline visual acuity during light exposure. RESULTS: Contrast thresholds values were higher in eyes treated with panretinal photocoagulation compared to un-treated eyes before illumination 4.2 +/- 1.2% vs. 3.1 +/- 1.7% (p=0.006), during background illumination 5.8 +/- 5.1% vs. 3.9 +/- 4.8% (p=0.001), and during spotlight exposure 5.6 +/- 2.2% vs. 3.2 +/- 1.8% (p<0.001). Furthermore, recovery time was longer both during background illumination, 20; 5-50 sec vs. 2; 2-80 sec. (md;range), (p<0.001) and during spotlight illumination 27; 5-70 sec vs. 2;1-60 sec. (md;range) (p<0.001). CONCLUSION: Eyes treated with panretinal photocoagulation had higher contrast threshold levels at baseline and during glare, as well as a prolonged visual recovery time compared to un-treated eyes with mild background retinopathy.
KW - contrast sensitivity
KW - glare
KW - panretinal photocoagulation
KW - diabetes
KW - visual recovery time
M3 - Article
VL - 78
SP - 672
EP - 676
JO - Acta Ophthalmologica Scandinavica
JF - Acta Ophthalmologica Scandinavica
SN - 1395-3907
IS - 6
ER -